Health Systems Build Enterprise Data Backbones
Hospitals are moving beyond basic dashboards to build robust data and AI backbones for their enterprise analytics. The strategic focus is on creating data pipelines that can support precision analytics, automate workflows, and scale clinical decision-making. For imaging providers, the ability to integrate mobile and outpatient imaging data into these enterprise platforms is becoming a key requirement for health system partnerships.
- The shift of imaging services to outpatient settings is accelerating, with projections indicating a 10% growth in standard outpatient imaging and a 14% increase in advanced imaging over the next decade. Currently, about 40% of all radiology procedures are conducted in outpatient centers rather than hospitals. - Health systems are increasingly developing "systemness" strategies to manage imaging services across a network of hospitals and outpatient sites, sometimes through joint ventures or acquisitions of freestanding imaging centers. This approach aims to capture the growing outpatient volume and improve operational efficiency. - The mobile medical imaging services market is forecasted to grow from $17.31 billion in 2026 to $21.13 billion by 2031, with hospitals and clinics currently accounting for over 65% of the revenue. Key players in this market include major equipment manufacturers like Siemens Healthineers, GE Healthcare, and Philips Healthcare. - A persistent shortage of radiologists and technologists is a significant operational challenge, with imaging volumes projected to rise annually while the workforce growth remains limited. In 2025, vacancy rates for CT and MRI technologists reached all-time highs of 19.4% and 17.4%, respectively. - Artificial intelligence is significantly impacting radiology workflows by automating routine tasks, categorizing and prioritizing urgent cases, and in some instances, increasing reporting efficiency by up to 40%. - As of late 2025, the FDA had approved over 1,000 AI-enabled devices for radiology, which represents about 77% of all medical AI authorizations. Leading vendors in this space include GE HealthCare, Siemens Healthineers, and Philips. - Changes in Medicare reimbursement are influencing imaging site-of-care decisions. While the 2025 Medicare Physician Fee Schedule saw an overall reduction in the conversion factor, reimbursement for certain procedures like CCTA was effectively doubled, encouraging outpatient service expansion. - Consolidation in the imaging market is evident through strategic acquisitions, such as RadNet's purchase of breast-AI vendor iCAD and GE HealthCare's acquisition of Intelligent Ultrasound, indicating a trend towards vertical integration of equipment and AI software.
